Blackiston Douglas J, Vien Khanh, Levin Michael
Allen Discovery Center, Tufts University, 200 Boston Avenue, Suite 4600, Medford, MA 02155 USA.
NPJ Regen Med. 2017 Mar 30;2:8. doi: 10.1038/s41536-017-0012-5. eCollection 2017.
The major goal of regenerative medicine is to repair damaged tissues and organ systems, thereby restoring their native functions in the host. Control of innervation by re-grown or implanted structures, and integration of the nascent nerves into behavioral/cognitive programs of the host, remains a critical barrier. In the case of sensory organs, this is particularly true, as afferent neurons must form connections with the host to communicate auditory, visual, and tactile information. embryos and tadpoles are powerful models for such studies, as grafting techniques allow for the creation of eyes and other sensory structures along the body axis, and the behavior of the resulting organism can be quantitatively analyzed. Previous work has demonstrated that ectopic eyes could be grafted in blinded tadpoles, allowing some of the animals to learn in a simple light-preference assay. Here, we show that it is possible to improve the efficiency of the process in the context of a novel image-forming vision assay, using a drug already approved for human use. Innervation of the host by ectopic eyes can be increased by targeting a serotonergic signaling mechanism: grafts treated with a 5-HT agonist strongly innervate the recipient compared with untreated grafts, without large-scale disruption of the host nervous system. Blind animals possessing eye grafts with the augmented innervation demonstrate increased performance over untreated siblings in wavelength-based learning assays. Furthermore, treated animals also exhibit enhanced visual pattern recognition, suggesting that the increased innervation in response to 5-HT activation leads to enhanced functional integration of the ectopic organ with the host central nervous system and behavioral programs. These data establish a model system and reveal a new roadmap using small molecule neurotransmitter drugs to augment innervation, integration, and function of transplanted heterologous organs in regenerative medicine.
再生医学的主要目标是修复受损组织和器官系统,从而在宿主体内恢复其天然功能。重新生长或植入的结构对神经支配的控制以及新生神经融入宿主的行为/认知程序,仍然是一个关键障碍。在感觉器官的情况下尤其如此,因为传入神经元必须与宿主形成连接以传递听觉、视觉和触觉信息。胚胎和蝌蚪是此类研究的有力模型,因为移植技术允许沿着身体轴创建眼睛和其他感觉结构,并且可以对所得生物体的行为进行定量分析。先前的研究表明,可以将异位眼移植到失明的蝌蚪中,使一些动物能够在简单的光偏好试验中学习。在这里,我们表明,在一种新的成像视觉试验的背景下,使用一种已被批准用于人类的药物,可以提高这一过程的效率。通过靶向血清素能信号传导机制,可以增加宿主被异位眼的神经支配:与未处理的移植物相比,用5-羟色胺(5-HT)激动剂处理的移植物对受体的神经支配更强,而不会对宿主神经系统造成大规模破坏。拥有神经支配增强的眼移植物的失明动物在基于波长的学习试验中表现出比未处理的同胞更好的性能。此外,经处理的动物还表现出增强的视觉模式识别能力,这表明对5-HT激活的神经支配增加导致异位器官与宿主中枢神经系统和行为程序的功能整合增强。这些数据建立了一个模型系统,并揭示了一条新的路线图,即使用小分子神经递质药物来增强再生医学中移植的异源器官的神经支配、整合和功能。